TickerFacts.

Dianthus Therapeutics, Inc. (DNTH): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$314.0K
Year ended 2022-12-31
-53.2%
3-year compound annual growth
-32.2%
5-year compound annual growth
$7.67M2016-12-31: $139.0K2017-12-31: $2.20M2018-12-31: $7.67M2019-12-31: $3.06M2020-12-31: $400.0K2021-12-31: $1.26M2022-12-31: $314.0K$314.0K
2016-12-31 Capital Expenditures (USD) 2022-12-31
Period endedCapital ExpendituresChange YoYSource filing
2022-12-31$314.0K-75.2%2023-03-23, From 2022-01-01
2021-12-31$1.26M+216.0%2023-03-23, From 2021-01-01
2020-12-31$400.0K-86.9%2022-03-08, From 2020-01-01
2019-12-31$3.06M-60.1%2021-03-03, From 2019-01-01
2018-12-31$7.67M+248.9%2020-03-03, From 2018-01-01
2017-12-31$2.20Mn/m2020-03-03, From 2017-01-01
2016-12-31$139.0Kn/a2019-03-19, From 2016-01-01